Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000801964 | SCV000941770 | benign | Intellectual disability, autosomal dominant 1 | 2024-04-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003380723 | SCV004089096 | uncertain significance | Inborn genetic diseases | 2023-09-13 | criteria provided, single submitter | clinical testing | The c.1249A>G (p.M417V) alteration is located in exon 9 (coding exon 4) of the MBD5 gene. This alteration results from a A to G substitution at nucleotide position 1249, causing the methionine (M) at amino acid position 417 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Ce |
RCV004584804 | SCV005074854 | uncertain significance | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | MBD5: PM5, BP4 |